Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
The product is being launched in August 2023
Subscribe To Our Newsletter & Stay Updated